BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 35177217)

  • 21. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
    Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
    BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.
    Chaemsaithong P; Gil MM; Chaiyasit N; Cuenca-Gomez D; Plasencia W; Rolle V; Poon LC
    Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia.
    Álvarez-Fernández I; Prieto B; Rodríguez V; Ruano Y; Escudero AI; Álvarez FV
    Clin Chim Acta; 2016 Dec; 463():150-157. PubMed ID: 27983995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy.
    August P; Helseth G; Cook EF; Sison C
    Am J Obstet Gynecol; 2004 Nov; 191(5):1666-72. PubMed ID: 15547540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
    Rana S; Burke SD; Karumanchi SA
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1019-S1034. PubMed ID: 33096092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
    Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
    Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expert review: preeclampsia Type I and Type II.
    Yagel S; Cohen SM; Admati I; Skarbianskis N; Solt I; Zeisel A; Beharier O; Goldman-Wohl D
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101203. PubMed ID: 37871693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.
    Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
    Reprod Biol Endocrinol; 2011 Sep; 9():124. PubMed ID: 21906313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of imminent preeclampsia at 35-37 weeks gestation.
    Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood.
    Chaiworapongsa T; Romero R; Gotsch F; Suksai M; Gallo DM; Jung E; Krieger A; Chaemsaithong P; Erez O; Tarca AL
    Am J Obstet Gynecol; 2023 May; 228(5):569.e1-569.e24. PubMed ID: 36336082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of angiogenic factors in the management of preeclampsia.
    Flint EJ; Cerdeira AS; Redman CW; Vatish M
    Acta Obstet Gynecol Scand; 2019 Jun; 98(6):700-707. PubMed ID: 30667052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and treatment of pregnancy-associated hypertension: what have we learned in the last 10 years?
    Remuzzi G; Ruggenenti P
    Am J Kidney Dis; 1991 Sep; 18(3):285-305. PubMed ID: 1882820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
    Shah DA; Khalil RA
    Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers.
    Metz TD; Allshouse AA; Euser AG; Heyborne KD
    Am J Obstet Gynecol; 2014 Nov; 211(5):512.e1-6. PubMed ID: 24769011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia.
    August P; Lenz T; Ales KL; Druzin ML; Edersheim TG; Hutson JM; Müller FB; Laragh JH; Sealey JE
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1612-21. PubMed ID: 2146881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension.
    Falcao S; Stoyanova E; Cloutier G; Maurice RL; Gutkowska J; Lavoie JL
    Hypertension; 2009 Dec; 54(6):1401-7. PubMed ID: 19822800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.